APG Asset Management N.V. Makes New $3.94 Million Investment in DaVita Inc. (NYSE:DVA)

APG Asset Management N.V. purchased a new position in shares of DaVita Inc. (NYSE:DVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 27,300 shares of the company's stock, valued at approximately $3,943,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita during the fourth quarter worth approximately $41,000. Venturi Wealth Management LLC increased its position in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares during the last quarter. Versant Capital Management Inc lifted its position in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the last quarter. Blue Trust Inc. grew its stake in DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after purchasing an additional 131 shares in the last quarter. Finally, Jones Financial Companies Lllp lifted its holdings in DaVita by 28.6% during the 4th quarter. Jones Financial Companies Lllp now owns 517 shares of the company's stock worth $77,000 after buying an additional 115 shares during the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Price Performance

DaVita stock traded down $0.22 during trading hours on Thursday, hitting $141.28. 387,232 shares of the company traded hands, compared to its average volume of 829,575. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The firm has a market cap of $11.30 billion, a P/E ratio of 13.16, a P/E/G ratio of 1.07 and a beta of 1.04. The firm's 50-day simple moving average is $150.47 and its two-hundred day simple moving average is $156.34. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on DVA. Cowen reiterated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Barclays upped their price objective on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. Finally, StockNews.com raised shares of DaVita from a "hold" rating to a "buy" rating in a report on Thursday, April 10th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, DaVita has an average rating of "Hold" and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.